E
LH icon

Ergoteles’s Labcorp LH Stock Holding History

Ergoteles’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,987
Closed -$807K – 1530
2022
Q4 		$807K Sell
3,987
-36,431
-90% -$7.12M 0.03% 535
2022
Q3 		$7.11M Buy
+40,418
New +$8.27M 0.25% 79
2022
Q2 		– Sell
-5,152
Closed -$1.17M – 1844
2022
Q1 		$1.17M Buy
5,152
+3,257
+172% +$766K 0.04% 384
2021
Q4 		$512K Sell
1,895
-1,839
-49% -$455K 0.02% 632
2021
Q3 		$903K Buy
+3,734
New +$941K 0.03% 405
2021
Q2 		– Sell
-3,259
Closed -$714K – 1599
2021
Q1 		$714K Buy
3,259
+378
+13% +$75.9K 0.02% 425
2020
Q4 		$504K Buy
2,881
+87
+3% +$15K 0.02% 447
2020
Q3 		$452K Buy
+2,794
New +$443K 0.06% 249

Other funds holding LH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Ergoteles's LH Position: Q1 2023 in Review

Ergoteles sold out of Labcorp (LH) in Q1 2023, closing a stake of 3,987 shares — an estimated $807K sold.

Ergoteles first reported a position in LH in Q3 2020 and held it in 8 quarters. The position peaked at $7.11M in Q3 2022. 940 funds tracked by Wall St. Rank hold LH as of Q1 2023.

  • Ergoteles reported no remaining Labcorp position as of Q1 2023 after selling out during the quarter.
  • Ergoteles sold 3,987 Labcorp shares in Q1 2023, an estimated $807K.
  • Ergoteles first reported a position in Labcorp in Q3 2020 and held it in 8 quarters.
  • Ergoteles's Labcorp position peaked at $7.11M in Q3 2022.
  • 940 funds tracked by Wall St. Rank held Labcorp as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.